William Blair Issues Pessimistic Outlook for ARCT Earnings
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) – William Blair cut their Q1 2025 earnings per share (EPS) estimates for Arcturus Therapeutics in a report issued on Thursday, March 13th. William Blair analyst M. Minter now forecasts that the biotechnology company will post earnings of ($1.39) per share for the quarter, down from their […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) – William Blair cut their Q1 2025 earnings per share (EPS) estimates for Arcturus Therapeutics in a report issued on Thursday, March 13th. William Blair analyst M. Minter now forecasts that the biotechnology company will post earnings of ($1.39) per share for the quarter, down from their […]
